Antibody Typhoid Vaccine

1

Review clinical trials related to Antibody Typhoid Vaccine. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV

Typhoid fever is a serious systemic infection caused by the enteric pathogen Salmonella enterica serovar typhi. S typhi is spread by the fecal-oral route. Although largely an endemic disease, S. typhi has epidemic potential. This research aims to determine the long-term immune response after administration of one dose of Bio TCV and PQed TCV vaccines in the population in Indonesia. Research participants will be taken from research participants who complete the Bio TCV (Typhoid 0319) Phase III clinical trial research included in the Main Study Group I.

Participants needed: 624
Trial details
Age: 6-60Biological sex: AllType: ObservationalSponsor: PT Bio FarmaUpdated: Jun 3, 2025Locations: 1Duration: 6 Months
Eligibility criteria

Healthy [+2]

History of uncontrolled coagulopathy or blood disorders contraindicating for phl...